Invention Grant
US08278348B2 Chondropsin-class antitumor V-atpase inhibitor compounds, compositions and methods of use thereof
有权
软骨素类抗肿瘤剂V-atpase抑制剂化合物，组合物及其使用方法
- Patent Title: Chondropsin-class antitumor V-atpase inhibitor compounds, compositions and methods of use thereof
- Patent Title (中): 软骨素类抗肿瘤剂V-atpase抑制剂化合物，组合物及其使用方法
-
Application No.: US12909979Application Date: 2010-10-22
-
Publication No.: US08278348B2Publication Date: 2012-10-02
- Inventor: Michael R. Boyd , Kirk R. Gustafson
- Applicant: Michael R. Boyd , Kirk R. Gustafson
- Applicant Address: US DC Washington
- Assignee: The United States of America, as represented by the Secretary of the Department of Health and Human Services
- Current Assignee: The United States of America, as represented by the Secretary of the Department of Health and Human Services
- Current Assignee Address: US DC Washington
- Agency: Leydig, Voit & Mayer
- Main IPC: A61K31/35
- IPC: A61K31/35 ; A61P35/00 ; A61P35/02 ; A61P25/28 ; A61P19/10 ; A61P27/06 ; A61P15/08 ; A61P13/00 ; A61P31/10 ; A61P35/04 ; A61P19/08
Abstract:
A composition comprising a substantially purified compound of the formula: in combination with at least one additional therapeutic agent, and methods of preventing or treating cancer and a condition treatable by the inhibition of vacuolar-type (H+)-ATPase.
Public/Granted literature
- US20110034547A1 CHONDROPSIN-CLASS ANTITUMOR V-ATPASE INHIBITOR COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF Public/Granted day:2011-02-10
Information query
